Tuesday, October 19, 2021
HomeFocus50th International Liver Conference, Vienna, Austria

50th International Liver Conference, Vienna, Austria

EASLSome research highlights from the European Association for the Study of the Liver’s 50th International Liver Conference, including a potential cure for hepatitis B virus infections, with a promising new treatment proving 100% successful in pre-clinical models and new hepatitis C virustreatment guidelines.

Potential cure for HBV
A potential cure for hepatitis B virus (HBV) infections, with a promising new treatment proving 100% successful in pre-clinical models.
[link url="http://www.medicalbrief.co.za/archives/potential-cure-for-hbv/"]More[/link]

New HCV treatment guidelines
EASL released its latest hepatitis C virus (HCV) treatment guidelines.
[link url="http://www.medicalbrief.co.za/archives/new-hcv-treatment-guidelines/"]More[/link]

HCV combination therapies show promise
A number of new HCV combination therapies show promise.
[link url="http://www.medicalbrief.co.za/archives/hcv-combination-therapies-show-promise/"]More[/link]

NASH has 50% higher death rate than NAFLD
A [b]British[/b] cohort of almost 1m people found that mortality from non-alcoholic steatohepatitis (NASH), over a 14-year period, was approximately 50% higher than for those with non-alcoholic fatty liver disease (NAFLD).
[link url="http://www.medicalbrief.co.za/archives/nash-has-50-higher-death-rate-than-nafld/"]More[/link]

NAFLD promotes coronary artery calcification
NAFLD plays a role in the early stages of coronary atherosclerosis and can also promote the development of coronary artery calcification.
[link url="http://www.medicalbrief.co.za/archives/nafld-found-to-promote-calcification-of-coronary-arteries/"]More[/link]

HCV increases cancer risk 'significantly'
Cancer rates in patients with HCV were significantly increased compared to the non-HCV cohort.
[link url="http://www.medicalbrief.co.za/archives/cancer-risks-increase-for-hcv-patients/"]More[/link]

In-patient cirrhosis deaths plummet
The largest US sampling to date found 'dramatic improvements' in the survival of patients with cirrhosis and liver failure.
[link url="http://www.medicalbrief.co.za/archives/in-patient-cirrhosis-deaths-plummet/"]More[/link]

HBV vaccination must be expanded
The universal infant hepatitis B virus (HBV) vaccination needs further expansion to significantly reduce HBV transmission and liver disease mortality.
[link url="http://www.medicalbrief.co.za/archives/hbv-vaccination-must-be-expanded/"]More[/link]

Subscribe to our Newsletter

Receive Medical Brief's free weekly e-newsletter.

* indicates required